According to the current analysis
of Reports and Data, the global Hemodialysis
and Peritoneal Dialysis market was valued at USD 69.58 billion in 2018
and is expected to reach USD 112.2 billion by the year 2026, at a CAGR of 6.2%.
Hemodialysis and peritoneal dialysis are used to treat kidney failure.
Hemodialysis uses a human-made membrane for filtration of waste and removal of
excess fluid from the blood. In contrast, peritoneal dialysis uses the lining
of the abdominal cavity and a solution known as dialysate for the elimination
of waste and excess fluid from the body.
The increasing number of patients
suffering from kidney diseases, an increased prevalence of diabetes along with
the preference of patients for dialysis treatment over kidney transplant are
the major factors contributing to the growth of global hemodialysis and
peritoneal dialysis market. Along with this, the rising geriatric population,
increasing investments for innovating dialysis products, technological
advancements in the products, and favorable reimbursement policies are factors
that drive the growth of the market. Various key players are engaged in
providing user friendly services such as home dialysis. Lack of organ donors as
compare to number of organ recipient, increasing organ rejection cases are also
expected to carve the population towards dialysis. Increasing kidney diseases
such as end-stage renal disease (ESRD), according to University of California
San Francisco approximately 2 million patients have ESRD across the globe and
is expected to rise in further years which is expected to grow the demand of
the market.
The key market players are
adopting various strategies such as product launch, partnerships, mergers, and
acquisitions to maintain their market position. For instance, in 2019,
Fresenius Medical Care, the world’s largest provider of dialysis products and
services, launched a 4008A dialysis machine. The company aims to improve
accessibility to life-sustaining dialysis treatment for patients who are living
with end-stage renal disease (ESRD) with the launch of their new product.
However, high cost and high risks and complications associated with dialysis
are the major hindrances for market growth during 2019-2026.
To identify the key trends in
the industry, click on the link below:
Further key findings from
the report suggest
- Favorable reimbursement policy such as Medicare in
U.S. is also expected to propel the growth
- Based on type, the hemodialysis market segment is
projected to dominate the market with nearly 80% market share during the
forecast period and is expected to grow at a CAGR of 6.4%
- Based on the water treatment system, portable water
disinfection system dominates the market with 60% market share
- Asia Pacific is expected to account for 17.5% market
share owing to the prevalence of diabetes and hypertension, and improving
healthcare infrastructure in the region.
- Implantation of an artificial kidney into human body
that is timely monitored by doctors is major factor restricting the growth
of the
- In 2018, in-center dialysis segment accounted for
68.5% market share and is expected to witness significant growth during
the forecast period owing to the increasing number of dialysis clinics
globally
- Key participants include Fresenius Medical Care AG
& Co., DaVita Healthcare Partners, Baxter International, B. Braun
Melsungen AG, Nikkiso, Nipro Corporation
No comments:
Post a Comment